Visiongain

A new report by visiongain predicts that the world market for cancer-treating drugs will reach $75 billion for 2012. That revenue forecast appears in Leading Anti-Cancer Drugs and Associated Market 2012-2022, published in February 2012.

Visiongain’s new analysis indicates that the military communications market will reach a value of $17.03bn in 2012, as armed forces around the world continue to invest in the military communications programmes and equipment.

A combination of ageing infrastructure, rising use of renewable energy sources, rising demand for electricity, and improvement of energy security are beginning to translate into growth in the super grid market.

17 February 2012. London, UK. Global oil trade is profoundly dependent on seaborne oil tankers for the transportation of crude oil. Over recent years the trading of refined petroleum products and petrochemicals by sea has also risen.

Visiongain's analysis indicates that the military aircraft avionics market will reach a value of $16.94bn in 2012, as militaries around the world continue to develop and upgrade their avionics capabilities for a number of military settings and roles.

The global healthcare packaging market is a complex and large market. The varied factors affecting the drug demand and consumption as well the development of medical practices will determine the growth of this market in future.

8 February 2012. London. UK. The global market for floating liquefied natural gas (FLNG) can be divided into two distinct areas: the conceptual floating liquefaction plants and the operational floating regasification units.

Visiongain's analysis indicates that the military helicopter market will reach a value of $19.4bn in 2012, as militaries worldwide continue to develop and upgrade their rotorcraft capabilities for a number of military settings and roles.

A new report by visiongain, a London-based business information provider predicts the global needle-free delivery devices market to be worth almost 5.9 billion dollars by 2022.

A new report by visiongain predicts that the world market for cell-based assays will reach 2.78 billion dollars in 2012. That sales forecast appears in Cell-Based Assays: World Market Prospects 2012-2022, published in January 2012.